Prehospital delay time in acute myocardial infarction: an exploratory study on relation to hospital outcomes and cost.
暂无分享,去创建一个
B. Drew | E. Froelicher | B J Drew | E S Froelicher | M A Caldwell | M. Caldwell | Erika Sivarajan Froelicher | Barbara J. Drew | Mary A. Caldwell
[1] Richard P. Lewis,et al. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction , 1996 .
[2] M. P. Larsen,et al. Prehospital delay interval for patients who use emergency medical services: the effect of heart-related medical conditions and demographic variables. , 1993, Annals of emergency medicine.
[3] H. White,et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction , 1996, BMJ.
[4] H. Fineberg,et al. A cost-effectiveness model for coronary thrombolysis/reperfusion therapy. , 1987, Journal of the American College of Cardiology.
[5] R. Luepker,et al. Consequences of a media campaign focusing on delay in acute myocardial infarction. , 1992, American Journal of Cardiology.
[6] David P Miller,et al. In-hospital cost of percutaneous coronary revascularization. Critical determinants and implications. , 1995, Circulation.
[7] F Van de Werf,et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. , 1996, Journal of the American College of Cardiology.
[8] A. Maggioni,et al. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. , 1993, Journal of the American College of Cardiology.
[9] L. Køber,et al. Determinants of delay between symptoms and hospital admission in 5978 patients with acute myocardial infarction. The TRACE Study Group. Trandolapril Cardiac Evaluation. , 1996, European heart journal.
[10] S. Schmidt,et al. The prehospital phase of acute myocardial infarction in the era of thrombolysis. , 1990, The American journal of cardiology.
[11] A. Jaffe,et al. Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. , 1986, The American journal of cardiology.
[12] S. Yusuf,et al. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. , 1995, Circulation.
[13] M. Eisenberg,et al. Delay between onset of chest pain and seeking medical care: the effect of public education. , 1989, Annals of emergency medicine.
[14] M. P. Larsen,et al. 'Call fast, Call 911': a direct mail campaign to reduce patient delay in acute myocardial infarction. , 1997, American journal of public health.
[15] C. Cannon,et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. , 1995, Journal of the American College of Cardiology.
[16] E. Braunwald,et al. Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial , 1993 .
[17] R. Kleiger,et al. Correction: Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy. , 1998, The New England journal of medicine.
[18] G. Taylor,et al. Effect of a two-year public education campaign on reducing response time of patients with symptoms of acute myocardial infarction. , 1991, The American journal of cardiology.
[19] R. Califf,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[20] R. M. Rubison,et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.
[21] E. Braunwald,et al. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial. , 1996, Circulation.
[22] A. Hasman,et al. Explaining cost variations in DRGs 'Acute Myocardial Infarction' by severity of illness. , 1994, Health policy.
[23] R. M. Rubison,et al. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Participants in the National Registry of Myocardial Infarction. , 1995, The American journal of cardiology.
[24] P. Kudenchuk,et al. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry) , 1996, The American journal of cardiology.
[25] C. Naylor,et al. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[26] Yuan Zhang,et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. , 1998, Circulation.
[27] J. Herlitz,et al. Prognosis in myocardial infarction in relation to gender. , 1994, American heart journal.
[28] J. Herlitz,et al. Delay time between onset of myocardial infarction and start of thrombolysis in relation to prognosis. , 1993, Cardiology.